Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts.

Br J Cancer · 2009 · PMC2676548 · PMID 19319133

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A fourth model, OCIP19, also showed growth inhibition, but this effect did not reach statistical significance, whereas there was no significant growth inhibition in OCIP18.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.